Literature DB >> 18780791

Cell type-specific DNA methylation patterns in the human breast.

Noga Bloushtain-Qimron1, Jun Yao, Eric L Snyder, Michail Shipitsin, Lauren L Campbell, Sendurai A Mani, Min Hu, Haiyan Chen, Vadim Ustyansky, Jessica E Antosiewicz, Pedram Argani, Marc K Halushka, James A Thomson, Paul Pharoah, Angel Porgador, Saraswati Sukumar, Ramon Parsons, Andrea L Richardson, Martha R Stampfer, Rebecca S Gelman, Tatiana Nikolskaya, Yuri Nikolsky, Kornelia Polyak.   

Abstract

Cellular identity and differentiation are determined by epigenetic programs. The characteristics of these programs in normal human mammary epithelium and their similarity to those in stem cells are unknown. To begin investigating these issues, we analyzed the DNA methylation and gene expression profiles of distinct subpopulations of mammary epithelial cells by using MSDK (methylation-specific digital karyotyping) and SAGE (serial analysis of gene expression). We identified discrete cell-type and differentiation state-specific DNA methylation and gene expression patterns that were maintained in a subset of breast carcinomas and correlated with clinically relevant tumor subtypes. CD44+ cells were the most hypomethylated and highly expressed several transcription factors with known stem cell function including HOXA10 and TCF3. Many of these genes were also hypomethylated in BMP4-treated compared with undifferentiated human embryonic stem (ES) cells that we analyzed by MSDK for comparison. Further highlighting the similarity of epigenetic programs of embryonic and mammary epithelial cells, genes highly expressed in CD44+ relative to more differentiated CD24+ cells were significantly enriched for Suz12 targets in ES cells. The expression of FOXC1, one of the transcription factors hypomethylated and highly expressed in CD44+ cells, induced a progenitor-like phenotype in differentiated mammary epithelial cells. These data suggest that epigenetically controlled transcription factors play a key role in regulating mammary epithelial cell phenotypes and imply similarities among epigenetic programs that define progenitor cell characteristics.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18780791      PMCID: PMC2532972          DOI: 10.1073/pnas.0805206105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells.

Authors:  Gabriela Dontu; Wissam M Abdallah; Jessica M Foley; Kyle W Jackson; Michael F Clarke; Mari J Kawamura; Max S Wicha
Journal:  Genes Dev       Date:  2003-05-15       Impact factor: 11.361

2.  Prospective identification of tumorigenic breast cancer cells.

Authors:  Muhammad Al-Hajj; Max S Wicha; Adalberto Benito-Hernandez; Sean J Morrison; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

3.  Serial analysis of gene expression.

Authors:  V E Velculescu; L Zhang; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1995-10-20       Impact factor: 47.728

4.  BMP4 initiates human embryonic stem cell differentiation to trophoblast.

Authors:  Ren-He Xu; Xin Chen; Dong S Li; Rui Li; Gregory C Addicks; Clay Glennon; Thomas P Zwaka; James A Thomson
Journal:  Nat Biotechnol       Date:  2002-11-11       Impact factor: 54.908

5.  Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9.

Authors:  Andrei V Krivtsov; David Twomey; Zhaohui Feng; Matthew C Stubbs; Yingzi Wang; Joerg Faber; Jason E Levine; Jing Wang; William C Hahn; D Gary Gilliland; Todd R Golub; Scott A Armstrong
Journal:  Nature       Date:  2006-07-16       Impact factor: 49.962

6.  Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity.

Authors:  Diego Pasini; Adrian P Bracken; Michael R Jensen; Eros Lazzerini Denchi; Kristian Helin
Journal:  EMBO J       Date:  2004-09-23       Impact factor: 11.598

7.  Tcf3 is an integral component of the core regulatory circuitry of embryonic stem cells.

Authors:  Megan F Cole; Sarah E Johnstone; Jamie J Newman; Michael H Kagey; Richard A Young
Journal:  Genes Dev       Date:  2008-03-15       Impact factor: 11.361

8.  Severe global DNA hypomethylation blocks differentiation and induces histone hyperacetylation in embryonic stem cells.

Authors:  Melany Jackson; Anna Krassowska; Nick Gilbert; Timothy Chevassut; Lesley Forrester; John Ansell; Bernard Ramsahoye
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

9.  Molecular definition of breast tumor heterogeneity.

Authors:  Michail Shipitsin; Lauren L Campbell; Pedram Argani; Stanislawa Weremowicz; Noga Bloushtain-Qimron; Jun Yao; Tatiana Nikolskaya; Tatiana Serebryiskaya; Rameen Beroukhim; Min Hu; Marc K Halushka; Saraswati Sukumar; Leroy M Parker; Karen S Anderson; Lyndsay N Harris; Judy E Garber; Andrea L Richardson; Stuart J Schnitt; Yuri Nikolsky; Rebecca S Gelman; Kornelia Polyak
Journal:  Cancer Cell       Date:  2007-03       Impact factor: 31.743

Review 10.  The novel BORIS + CTCF gene family is uniquely involved in the epigenetics of normal biology and cancer.

Authors:  Elena M Klenova; Herbert C Morse; Rolf Ohlsson; Victor V Lobanenkov
Journal:  Semin Cancer Biol       Date:  2002-10       Impact factor: 15.707

View more
  110 in total

1.  The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors.

Authors:  Lauren L C Marotta; Vanessa Almendro; Andriy Marusyk; Michail Shipitsin; Janina Schemme; Sarah R Walker; Noga Bloushtain-Qimron; Jessica J Kim; Sibgat A Choudhury; Reo Maruyama; Zhenhua Wu; Mithat Gönen; Laura A Mulvey; Marina O Bessarabova; Sung Jin Huh; Serena J Silver; So Young Kim; So Yeon Park; Hee Eun Lee; Karen S Anderson; Andrea L Richardson; Tatiana Nikolskaya; Yuri Nikolsky; X Shirley Liu; David E Root; William C Hahn; David A Frank; Kornelia Polyak
Journal:  J Clin Invest       Date:  2011-07       Impact factor: 14.808

Review 2.  The epigenetics of breast cancer.

Authors:  Jovana Jovanovic; Jo Anders Rønneberg; Jörg Tost; Vessela Kristensen
Journal:  Mol Oncol       Date:  2010-04-29       Impact factor: 6.603

3.  Altered antisense-to-sense transcript ratios in breast cancer.

Authors:  Reo Maruyama; Michail Shipitsin; Sibgat Choudhury; Zhenhua Wu; Alexei Protopopov; Jun Yao; Pang-Kuo Lo; Marina Bessarabova; Alex Ishkin; Yuri Nikolsky; X Shirley Liu; Saraswati Sukumar; Kornelia Polyak
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

4.  Cell specific patterns of methylation in the human placenta.

Authors:  Ariadna Grigoriu; Jose Carlos Ferreira; Sanaa Choufani; Dora Baczyk; John Kingdom; Rosanna Weksberg
Journal:  Epigenetics       Date:  2011-03-01       Impact factor: 4.528

5.  The forkhead box transcription factor FOXC1 promotes breast cancer invasion by inducing matrix metalloprotease 7 (MMP7) expression.

Authors:  Steven T Sizemore; Ruth A Keri
Journal:  J Biol Chem       Date:  2012-05-29       Impact factor: 5.157

6.  Gene expression profiling of human breast tissue samples using SAGE-Seq.

Authors:  Zhenhua Jeremy Wu; Clifford A Meyer; Sibgat Choudhury; Michail Shipitsin; Reo Maruyama; Marina Bessarabova; Tatiana Nikolskaya; Saraswati Sukumar; Armin Schwartzman; Jun S Liu; Kornelia Polyak; X Shirley Liu
Journal:  Genome Res       Date:  2010-11-02       Impact factor: 9.043

7.  FoxC1 promotes epithelial-mesenchymal transition through PBX1 dependent transactivation of ZEB2 in esophageal cancer.

Authors:  Xiaoming Zhu; Li Wei; Yangqiu Bai; Sen Wu; Shuangyin Han
Journal:  Am J Cancer Res       Date:  2017-08-01       Impact factor: 6.166

Review 8.  Epigenomics and breast cancer.

Authors:  Pang-Kuo Lo; Saraswati Sukumar
Journal:  Pharmacogenomics       Date:  2008-12       Impact factor: 2.533

9.  High level of FOXC1 expression is associated with poor prognosis in pancreatic ductal adenocarcinoma.

Authors:  Lei Wang; Feng Gu; Chao-Ying Liu; Run-Jie Wang; Jiang Li; Jun-Ying Xu
Journal:  Tumour Biol       Date:  2012-12-16

10.  Inference of tumor evolution during chemotherapy by computational modeling and in situ analysis of genetic and phenotypic cellular diversity.

Authors:  Vanessa Almendro; Yu-Kang Cheng; Amanda Randles; Shalev Itzkovitz; Andriy Marusyk; Elisabet Ametller; Xavier Gonzalez-Farre; Montse Muñoz; Hege G Russnes; Aslaug Helland; Inga H Rye; Anne-Lise Borresen-Dale; Reo Maruyama; Alexander van Oudenaarden; Mitchell Dowsett; Robin L Jones; Jorge Reis-Filho; Pere Gascon; Mithat Gönen; Franziska Michor; Kornelia Polyak
Journal:  Cell Rep       Date:  2014-01-23       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.